|
private:neurosciencetechnologiesltd.-2
|
1541683
|
May 30th, 2019 12:00AM
|
Neuroscience Technologies
|
248
|
7.00
|
Open
|
Research
|
May 30th, 2019 01:46PM
|
May 30th, 2019 01:46PM
|
NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.
We use microneurography to quantify spontaneous activity in pain fibres in pre-clinical development and in the clinic.
This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.
|
Open
|
microneurography, neuropathic pain, nerve excitability, small nerve fibres, preclinical research, clinical research, pain models, pain neurophysiology, patient services
|
Open
|
Barcelona Science Park, Helix Building, Baldiri Reixac 15-21
|
Barcelona
|
Catalonia
|
ES
|
08028
|
|
Neuroscience Technologies Ltd.
|
|
Pharmaceuticals & Biotechnology
|
|
private:neurosciencetechnologiesltd.-2
|
1541683
|
Feb 17th, 2018 12:00AM
|
Neuroscience Technologies Ltd.
|
134
|
8.00
|
Open
|
Research
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.
We use microneurography to quantify spontaneous activity in pain fibres in pre-clinical development and in the clinic.
This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.
|
|
|
|
|
|
|
|
|
|
Neuroscience Technologies Ltd.
|
|
Pharmaceuticals & Biotechnology
|
|
private:neurosciencetechnologiesltd.-2
|
1541683
|
Feb 16th, 2018 12:00AM
|
Neuroscience Technologies Ltd.
|
134
|
8.00
|
Open
|
Research
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.
We use microneurography to quantify spontaneous activity in pain fibres in pre-clinical development and in the clinic.
This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.
|
|
|
|
|
|
|
|
|
|
Neuroscience Technologies Ltd.
|
|
Pharmaceuticals & Biotechnology
|
|
private:neurosciencetechnologiesltd.-2
|
1541683
|
Feb 15th, 2018 12:00AM
|
Neuroscience Technologies Ltd.
|
134
|
8.00
|
Open
|
Research
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.
We use microneurography to quantify spontaneous activity in pain fibres in pre-clinical development and in the clinic.
This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.
|
|
|
|
|
|
|
|
|
|
Neuroscience Technologies Ltd.
|
|
Pharmaceuticals & Biotechnology
|
|
private:neurosciencetechnologiesltd.-2
|
1541683
|
Feb 14th, 2018 12:00AM
|
Neuroscience Technologies Ltd.
|
134
|
8.00
|
Open
|
Research
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.
We use microneurography to quantify spontaneous activity in pain fibres in pre-clinical development and in the clinic.
This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.
|
|
|
|
|
|
|
|
|
|
Neuroscience Technologies Ltd.
|
|
Pharmaceuticals & Biotechnology
|
|
private:neurosciencetechnologiesltd.-2
|
1541683
|
Feb 13th, 2018 12:00AM
|
Neuroscience Technologies Ltd.
|
134
|
8.00
|
Open
|
Research
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.
We use microneurography to quantify spontaneous activity in pain fibres in pre-clinical development and in the clinic.
This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.
|
|
|
|
|
|
|
|
|
|
Neuroscience Technologies Ltd.
|
|
Pharmaceuticals & Biotechnology
|
|
private:neurosciencetechnologiesltd.-2
|
1541683
|
Feb 12th, 2018 12:00AM
|
Neuroscience Technologies Ltd.
|
134
|
8.00
|
Open
|
Research
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.
We use microneurography to quantify spontaneous activity in pain fibres in pre-clinical development and in the clinic.
This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.
|
|
|
|
|
|
|
|
|
|
Neuroscience Technologies Ltd.
|
|
Pharmaceuticals & Biotechnology
|
|
private:neurosciencetechnologiesltd.-2
|
1541683
|
Feb 11th, 2018 12:00AM
|
Neuroscience Technologies Ltd.
|
134
|
8.00
|
Open
|
Research
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.
We use microneurography to quantify spontaneous activity in pain fibres in pre-clinical development and in the clinic.
This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.
|
|
|
|
|
|
|
|
|
|
Neuroscience Technologies Ltd.
|
|
Pharmaceuticals & Biotechnology
|
|
private:neurosciencetechnologiesltd.-2
|
1541683
|
Feb 10th, 2018 12:00AM
|
Neuroscience Technologies Ltd.
|
134
|
8.00
|
Open
|
Research
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.
We use microneurography to quantify spontaneous activity in pain fibres in pre-clinical development and in the clinic.
This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.
|
|
|
|
|
|
|
|
|
|
Neuroscience Technologies Ltd.
|
|
Pharmaceuticals & Biotechnology
|
|
private:neurosciencetechnologiesltd.-2
|
1541683
|
Feb 9th, 2018 12:00AM
|
Neuroscience Technologies Ltd.
|
134
|
8.00
|
Open
|
Research
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.
We use microneurography to quantify spontaneous activity in pain fibres in pre-clinical development and in the clinic.
This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.
|
|
|
|
|
|
|
|
|
|
Neuroscience Technologies Ltd.
|
|
Pharmaceuticals & Biotechnology
|